Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy (LSE: FARN) is trading at £0.35, about ₹45 at today's GBP/INR rate, as of 9 Oct 2026, 6:37 AM ET, down 4.11% today. Indian residents can buy Faron Pharmaceuticals Oy from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
£0.35
Today's high
£0.38
52 week low
£0.34
52 week high
£2.10
FARN opened at £0.35, closed previously at £0.37, and has traded between £0.34 and £2.10 over the past 52 weeks.
About
Established in Turku, Finland, in 2003, Faron Pharmaceuticals Oy operates as a clinical-stage biotechnology firm dedicated to the discovery and advancement of novel pharmaceutical solutions. The company's core focus lies in harnessing immune modulation to develop proprietary drug candidates addressing significant unmet medical needs. Their pipeline spans critical areas such as immuno-oncology, organ safeguarding, and regenerative medicine. Among its leading therapeutic candidates is Traumakine, an intravenous interferon beta-1a treatment under investigation for conditions including acute respiratory distress syndrome (ARDS), COVID-19, acute kidney injury, cardiac protection, solid organ transplant, and ischemia reperfusion injury. Another key asset is Bexmarilimab, an innovative precision cancer immunotherapy designed to target solid tumors, non-small cell lung carcinoma, and hematological malignancies. Additionally, Faron is developing Haematokine, a new chemical entity acting as an AOC3 inhibitor, aimed at treating hematological malignancies and bone marrow-related conditions.
Key statistics
Avg. volume
64.53K
Market cap
£69.28M
P/E Ratio
-3.23
Price-to-sales ratio
0.00
Enterprise value
€234.39M
Free cash flow yield
-8.17%
Debt-to-equity ratio
1.54
Return on equity
147.28%
ROIC
-232.89%
Beta
1.12
Dividend yield
0.00%
Last dividend
£0.00
Financial overview
Revenue
€0.00
Earnings per share
-€0.25
Free cash flow
-€18.14M
Net profit margin
0.00%
Gross margin
0.00%
EBITDA
-€19.93M
Revenue growth
0.00%
Similar securities
This is not an investment recommendation
How to buy Faron Pharmaceuticals Oy from India
Indian residents can buy Faron Pharmaceuticals Oy shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers. Read the full guide: how to invest in Faron Pharmaceuticals Oy from India
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to GBP.
Search for Faron Pharmaceuticals Oy and place an order
Find Faron Pharmaceuticals Oy by name or by its ticker, FARN, and choose an order type. Faron Pharmaceuticals Oy trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Faron Pharmaceuticals Oy position in GBP and INR. Faron Pharmaceuticals Oy pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Trading and taxes when buying Faron Pharmaceuticals Oy from India
Trading and limits
- Trading hours
- 8:00 am – 4:30 pm UK
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneFaron Pharmaceuticals Oy does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Transaction tax
- The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it.
FAQs
Can Indian residents buy Faron Pharmaceuticals Oy stock?
Yes. Faron Pharmaceuticals Oy (FARN) has been listed on the London Stock Exchange since 2015, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to GBP. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Faron Pharmaceuticals Oy share cost in rupees?
One Faron Pharmaceuticals Oy share is £0.35 — about ₹45 at a GBP/INR rate of 127.98 on 8 Oct 2026. Both the Faron Pharmaceuticals Oy price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Faron Pharmaceuticals Oy from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Faron Pharmaceuticals Oy shares taxed in India?
Non-residents are exempt from UK capital gains tax on the disposal of listed shares, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the GBP/INR rate on the purchase and the sale date, so the rupee move counts alongside the Faron Pharmaceuticals Oy price. Paasa issues a capital-gains statement for your return.
Does Faron Pharmaceuticals Oy pay a dividend?
No. Faron Pharmaceuticals Oy does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Faron Pharmaceuticals Oy from India?
The London Stock Exchange trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when the UK is on standard time. Orders can only execute during that window.
Is Faron Pharmaceuticals Oy a United Kingdom company, and does that change how it is taxed?
Faron Pharmaceuticals Oy trades on the London Stock Exchange in GBP, but the company is domiciled in Finland. Faron Pharmaceuticals Oy trades as an ordinary share listed directly in the UK, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Are there transaction taxes when buying Faron Pharmaceuticals Oy?
The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it. This is charged by the market, not by Paasa.
Do I have to declare Faron Pharmaceuticals Oy shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Faron Pharmaceuticals Oy holding, its cost and its closing value.
How do I sell Faron Pharmaceuticals Oy and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in GBP in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.